Your shopping cart is empty!
The Clinical and Laboratory Standards Institute (CLSI) is a global, nonprofit, standards-developing organization that promotes the development and use of voluntary consensus standards and guidelines within the healthcare community. For healthcare professionals, CLSI documents offer practical operating guidelines that lead to consistent practices, precision, and efficient use of resources. For industry, they promote effective use of healthcare technologies, and provide cost-and time-saving procedures for product development and approval. For government, these tools streamline the regulatory process. For the entire healthcare community, CLSI documents assure the levels of excellence and consistency that promote improved quality of life.
Nucleic Acid Amplification Assays for Molecular Hematopathology; Approved Guideline-Second Edition,MM05A2E
$90.00 $180.00
Preparation and Testing of Reagent Water in the Clinical Laboratory; Approved Guideline, Fourth Edition - GP40A4AMDE
Principles and Procedures for Detection of Fungi in Clinical Specimens - Direct Examination and Culture; Approved Guideline, M54A
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard-Ninth Edition & Performance Standards for Antimicrobial Susceptibiliy Testing; Twenty Second Informational Supplement, M07A8E, M100S20E
$146.00 $292.48
Generation, Presentation, and Application of Antimicrobial Susceptibility Test Data for Bacteria of Animal Origin; A Report, VET05RE
Performance Standards for Antimicrobial Susceptibility Testing; Twenty First Informational Supplement, M100S21
$143.00 $287.78
Assessment of Fetal Lung Maturity by the Lamellar Body Count; Approved Guideline, C58AE
Specimen Labels: Content and Location, Fonts, and Label Orientation; Approved Standard, AUTO12AE
Procedures for the Erythrocyte Sedimentation Rate Test; Approved Standard - Fifth Edition, H02A5
Quality Management System: Equipment; Approved Guideline, QMS13AE
Newborn Screening for Cystic Fibrosis; Approved Guideline, ILA35A2E
$100.00 $200.94
Quantitative D-dimer for the Exclusion of Venous Thromboembolic Disease; Proposed Guideline, H59AE
